The phrase "alternatively this study" is not correct as it lacks proper punctuation or conjunction to connect the ideas.
You can use it when presenting an alternative perspective or option related to a study, but it should be rephrased for clarity.
Example: "Alternatively, this study suggests a different approach to the problem."
Alternatives: "On the other hand, this study" or "In contrast, this study".
Alternatively, this study provides an example of a role for NFAT in the context of the nervous system, a role that is becoming more common.
Alternatively, this study was inadequately powered to detect such changes.
Alternatively, this study was limited by the use of checklists of negative life events.
Alternatively, this study also shows that the dose of MMC per BSA is an independent risk factor for developing neutropenia.
Alternatively, this study reported that individuals with diabetes had either weaker (men) or not stronger (women) muscle strength than individuals without diabetes despite larger muscle mass.
Alternatively, this study has been able to synthesise the extant literature to formulate a matrix of dimensions and demarcations that will enable health authorities to assess local health needs and plan an appropriate set of core services accordingly.
Alternatively, in this study, we explore the consequences of such collaboration on research quality.
Following the child development literature (Heckman and Kautz 2013), we term scores from these tests as "pre-school cognitive skills" and use "pre-school cognitive skills", "initial academic skills", and "initial cognitive endowment" alternatively in this study.
Alternatively, in this study, the mathematical complexity of the CTAP is overcome by adopting an intuitive interpretation of capacity; that is, the Lagrange multipliers of the capacity constraints are interpreted as additional delay imposed on the oversaturated roads to make them saturated.
Alternatively, as this study suggests, maintaining >20 mg/L sulfate conditions may also significantly reduce MeHg risk.
Alternatively, in this study, we investigated the effects of these three polymorphisms on the survival time of 816 lung cancer cases, subdivided on the basis of their different histopathological presentation and clinical stages (NSCLC: I, II, III, IV and SCLC: extended or limited).
